Stocks and InvestingStocks and Investing
Thu, July 22, 2021
Wed, July 21, 2021
Tue, July 20, 2021
Mon, July 19, 2021
Fri, July 16, 2021

Vikram Purohit Maintained (TBPH) at Buy with Decreased Target to $27 on, Jul 16th, 2021


Published on 2024-10-27 17:14:04 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Decreased Target from $28 to $27 on, Jul 16th, 2021.

Vikram has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram


  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $36 on, Monday, June 28th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $32 on, Wednesday, May 5th, 2021